Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioarginine in Patients With COPD
NCT05412160Completed
- Sponsor
- University of Milan
- Start
- Jan 2023
- Primary completion
- Dec 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial in chronic obstructive pulmonary disease (COPD) comparing BioArginine with Placebo (2 arms). Primary endpoint: Chronic Respiratory disease Questionnaire at 6 weeks. Started Jan 2023; status: completed.
02
Drugs
bioarginine
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT05412160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05412160.